N-acetylglucosamine-1-phosphate uridyltransferase

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (15:20, 29 December 2020) (edit) (undo)
 
(4 intermediate revisions not shown.)
Line 1: Line 1:
-
<StructureSection load='2v0j' size='340' side='right' caption='GlmU complex with its reaction product UDP-GlcNAC, PEG, Mg++, So4, tetraethylene glycol and triethylene glycol (PDB code [[2v0j]])' scene=''>
+
<StructureSection load='2v0j' size='400' side='right' caption='GlmU complex with its reaction product UDP-GlcNAC, PEG, Mg++, So4, tetraethylene glycol and triethylene glycol (PDB code [[2v0j]])' scene='84/841078/Cv/1'>
== Function ==
== Function ==
-
'''N-acetylglucosamine-1-phosphate uridyltransferase''' (GlmU} or '''bifunctional protein GlmU''' is a bifunctional acetyltransferase/uridyltransferase that catalyzes the formation of UDP-GlcNAc from glucosamine-1-phosphate (G1P)(<ref>PMID:19237750</ref>.)
+
'''N-acetylglucosamine-1-phosphate uridyltransferase''' (GlmU) or '''bifunctional protein GlmU''' is a bifunctional acetyltransferase/uridyltransferase that catalyzes the formation of UDP-GlcNAc from glucosamine-1-phosphate (G1P)(<ref>PMID:19237750</ref>.)
== Relevance ==
== Relevance ==
-
GlmU is essensial enzyme participating in the biosynthetic pathway for production of peptidoglycans which constitute the mycobacterial cell wall. Hence the inhibition of GlmU is a potential anti-tuberculosis drug target<ref>PMID:3=18573680</ref>.
+
GlmU is essensial enzyme participating in the biosynthetic pathway for production of peptidoglycans which constitute the mycobacterial cell wall. Hence the inhibition of GlmU is a potential anti-tuberculosis drug target<ref>PMID:318573680</ref>.
== Structural highlights ==
== Structural highlights ==
 +
 +
The UDP-GlcNAc binds to GlmU in the enzyme's N-terminal domain and the majority of the key active site residues are highly conserved across the bacterial GlmU family. The 3D structure of the complex shows an exposed <scene name='84/841078/Cv/4'>uracil binding pocket</scene>, GlcNAc interacting pocket and a lipophilic pocket <ref>PMID:18029420</ref>. <scene name='84/841078/Cv/5'>Surface representation of the uracil binding pocket</scene>.
</StructureSection>
</StructureSection>

Current revision

GlmU complex with its reaction product UDP-GlcNAC, PEG, Mg++, So4, tetraethylene glycol and triethylene glycol (PDB code 2v0j)

Drag the structure with the mouse to rotate

3D structures of GlmU

Updated on 29-December-2020

References

  1. Zhang Z, Bulloch EM, Bunker RD, Baker EN, Squire CJ. Structure and function of GlmU from Mycobacterium tuberculosis. Acta Crystallogr D Biol Crystallogr. 2009 Mar;65(Pt 3):275-83. Epub 2009, Feb 20. PMID:19237750 doi:10.1107/S0907444909001036
  2. . PMID:318573680
  3. Mochalkin I, Lightle S, Zhu Y, Ohren JF, Spessard C, Chirgadze NY, Banotai C, Melnick M, McDowell L. Characterization of substrate binding and catalysis in the potential antibacterial target N-acetylglucosamine-1-phosphate uridyltransferase (GlmU). Protein Sci. 2007 Dec;16(12):2657-66. PMID:18029420 doi:http://dx.doi.org/16/12/2657

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Michal Harel

Personal tools